Mailing HPV Self-Sampling Kits to Patients Boosted Cervical Cancer Screening The strategy was effective for patients who were due or overdue for screening Nov 28, 2023
FDA Approves First Therapy for Progressive Desmoid Tumors Nirogacestat reduced the risk of disease progression or death by 71% in randomized trial Nov 28, 2023
Diagnostic Imaging Not Yet Enough for Biopsy-Free Radical Prostatectomy Study validates concerns about benign prostatic hyperplasia-related PSMA-PET false positives Nov 27, 2023
Chemoimmunotherapy Improves Pathologic Outcomes in Gastroesophageal Carcinoma Adding atezolizumab to FLOT led to more downstaging, complete regressions versus chemo alone Nov 24, 2023
Osimertinib Shows Activity in NSCLC With Uncommon EGFR Mutations Researchers suggest the drug is a promising option for this rare subgroup Nov 22, 2023
Cancer Patient's Final Act: Destroying Medical Debt Viral campaign will erase some $60 million in medical debt Nov 22, 2023
Cancer Drug Recall; Long COVID and Reinfection; WHO Staffer Killed in Gaza Health news and commentary from around the Web gathered by 鶹ý staff Nov 22, 2023
HPV Tumor DNA May Offer Early Warning of Cervical Cancer at High Risk of Relapse Worse PFS associated with circulating tumor DNA detected as early as end of treatment Nov 21, 2023
Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALL However, it may benefit children at increased risk of thrombosis Nov 20, 2023
Alteplase Not Harmful in NOAC Users, Even in a More Bleeding-Prone Cohort No excess brain bleeds in an Asian population receiving lytic therapy for stroke Nov 20, 2023
Nudging Parents Plus Auditing Providers Increased HPV Vaccine Uptake in Tweens Interventions worked best in combination, according to cluster randomized trial Nov 20, 2023
Shooting at Psych Hospital; Rosalynn Carter Dies; Millions in Medical Debt Canceled Health news and commentary from around the Web gathered by 鶹ý staff Nov 20, 2023
Reprogramming Tumors; Bad Stool Samples; Human Experiences in Cancer Care News, features, and commentary about cancer-related issues Nov 17, 2023
First AKT Inhibitor Approved for Advanced Breast Cancer Capivasertib plus fulvestrant doubled progression-free survival versus fulvestrant-placebo Nov 17, 2023
Opioid Doc Sentenced; World's First Sickle Cell Gene Tx; FTC Warns Diet Influencers Health news and commentary from around the Web gathered by 鶹ý staff Nov 17, 2023
FDA Panel: Tolerating Approval Outliers Would Set 'Dangerous Precedent' No easy answers for two drugs for rare lymphoma on long cruise with accelerated approval Nov 16, 2023
ASTRO Updates Guidelines on Partial Breast Irradiation for Early Invasive Cancer Evidence from RCTs indicates "oncologic equivalence" between partial and whole-breast irradiation Nov 16, 2023
FDA OKs New Option for Advanced ROS1-Positive Lung Cancer Drug achieved high response rates in TKI-naive and TKI-pretreated patients Nov 16, 2023
'We're Not There Yet': CAR T-Cell Therapy for Renal Cell Carcinoma Potential standard of care after current therapies, but key obstacles remain in the way Nov 15, 2023
FDA OKs Product to Thwart Bloodstream Infections During Dialysis Taurolidine-heparin solution reduced infections by 71% versus heparin alone Nov 15, 2023
Targeting New Pathways to Improve Outcomes in Renal Cell Carcinoma Building on recent success requires intervention at multiple steps in the cancer immunity cycle Nov 14, 2023
Lymphoma Drug Copanlisib to Be Pulled From U.S. Market Failed confirmatory trial takes down another PI3K inhibitor Nov 14, 2023
Diabetes Linked to Higher Colorectal Cancer Risk Associated risks highest in those with recent diagnoses Nov 14, 2023
No Boost in Outcomes for Clear Cell RCC With Higher Belzutifan Dose A quarter of patients responded whether at the recommended or higher dose Nov 13, 2023
Pancreatic Cancer Doesn't Have to Be a Death Sentence Early detection is the key to increasing survival rates Nov 13, 2023
Tyrosine Kinase Inhibitor Active in Heavily Treated Renal Cell Carcinoma Responses to "special drug" zanzalintinib in cabozantinib-exposed and unexposed patients Nov 11, 2023
Zoonotic Spillovers; DNA and RNA Testing for Cancer Risk Also in TTHealthWatch: genes and health conditions among Icelanders Nov 11, 2023 podcast
First Treatment Approved for Genetic Clotting Disorder Adzynma indicated as prophylactic or on-demand enzyme replacement therapy in cTTP Nov 10, 2023
Vitamin D for Neuropathy; Good & Bad News for CAR-T; New Labeling for Surgical Mesh News, features, and commentary about cancer-related issues Nov 10, 2023
Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer Alone or combined with a PD-1 inhibitor, ubamatamab showed promise in phase I trial Nov 09, 2023
Moving Beyond the 'Angelina Jolie Effect' to Address Cancer Disparities A "local heroes effect" can better reach communities of color Nov 09, 2023
New Oral Drug Approved for Metastatic Colorectal Cancer In phase III trials of pretreated patients, fruquintinib improved survival versus placebo Nov 09, 2023
Novel Therapies Show Early Promise in Advanced Gastroesophageal Cancers Results look good, but more data needed Nov 08, 2023
Senate Confirms Monica Bertagnolli as Next NIH Director Vote was 62-36 in favor of the current National Cancer Institute director Nov 07, 2023
FDA Panel Backs High-Risk Designation for Salvaged Blood Irradiators With Class III designation, sponsors would have to prove safety, efficacy with randomized trials Nov 07, 2023
T-DXd Tied to Encouraging Survival in HER2-Expressing Gyn Cancers More responses, longer OS in subset with the highest levels of HER2 expression Nov 07, 2023
Sexual Health Suffered After Radical Hysterectomy for Early Cervical Cancer Compared with simple hysterectomy, analysis shows more sexual toxicities, worse quality of life Nov 07, 2023
Lung Cancer Survival High at 20 Years With Screen-Detected Tumors After two decades, lung cancer-specific survival remained at 81% in I-ELCAP program Nov 07, 2023
Mixed Results for Tiragolumab/Atezolizumab Combo in PD-L1+ Recurrent Cervical Cancer Overall response beats historical benchmark, but misses significance target Nov 06, 2023
RAF/MEK and FAK Inhibitor Combo Effective in Low-Grade Serous Ovarian Cancer Impressive overall response rate with avutometinib-defactinib in RAMP 201 trial Nov 05, 2023
